People: MAKO Surgical Corp. (MAKO.O)
MAKO.O on Consolidated Issue listed on NASDAQ Global Market
11.63USD
9 Feb 2010
11.63USD
9 Feb 2010
Price Change (% chg)
$0.10 (+0.87%)
$0.10 (+0.87%)
Prev Close
$11.63
$11.63
Open
--
--
Day's High
$11.78
$11.78
Day's Low
$11.40
$11.40
Volume
76,510
76,510
Avg. Vol
162,381
162,381
52-wk High
$13.83
$13.83
52-wk Low
$6.18
$6.18
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
| Ferre, Maurice | 48 | Chairman of the Board, President, Chief Executive Officer | |
| LaPorte, Fritz | 39 | 2008 | Chief Financial Officer, Senior Vice President - Finance and Administration, Treasurer |
| Abovitz, Rony | 38 | Senior Vice President, Chief Technology Officer | |
| Frank, Menashe | 42 | Senior Vice President, General Counsel, Secretary | |
| Nunes, Steven | 50 | Senior Vice President - Sales and Marketing | |
| Delevic, Ivan | 43 | 2009 | Senior Vice President - Strategic Marketing and Business Development |
| Moffat, Duncan | 48 | 2008 | Senior Vice President - Operations |
| Federico, Charles | 60 | 2009 | Lead Director |
| Blumenfeld, S. Morry | 71 | 2005 | Director |
| Chao, Marcelo | 42 | 2007 | Director |
| Dewey, Christopher | 64 | 2004 | Director |
| Moll, Frederic | 57 | 2007 | Director |
| Pruitt, William | 68 | 2008 | Director |
| Savarese, John | 40 | 2008 | Director |
| Freund, John | 55 | 2008 | Director |
Biographies
| Name | Description |
|---|---|
| Ferre, Maurice | Dr. Maurice R. Ferre, M.D. founding President, Chief Executive Officer and current Chairman of the Board of Directors of MAKO Surgical Corp., has been with the Company since its inception in November 2004. In May 2004, Dr. Ferre became Chief Executive Officer of Z-KAT, Inc., a surgical navigation medical device company that incorporated MAKO Surgical Corp. In 1993, Dr. Ferre founded Visualization Technology, Inc., a medical device company for image-guided surgery, and served as its Chief Executive Officer until the company was acquired by GE Healthcare in April 2002. Dr. Ferre served as Vice President of Strategic Development at GE Navigation, a division of GE Healthcare, from April 2002 until April 2004. Dr. Ferre holds a B.A. in biology from Bennington College and an M.P.H. and an M.D. from Boston University. |
| LaPorte, Fritz | Mr. Fritz L. LaPorte, Senior Vice President of Finance and Administration, Chief Financial Officer and Treasurer of MAKO Surgical Corp., has been with the Company since inception in November 2004. From 2001 to November 2004, Mr. LaPorte served as Chief Financial Officer of Z-KAT, Inc. From 1997 to 2000, Mr. LaPorte served as the Director of Finance for Holy Cross Hospital, Inc., a 580-bed acute care facility in Fort Lauderdale, Florida. From 1993 to 1997, Mr. LaPorte served as a Senior Auditor in the Assurance Healthcare Group of Ernst & Young LLP, our independent registered public accounting firm. Mr. LaPorte holds a B.B.A. in accounting from Florida Atlantic University and is a Certified Public Accountant. |
| Abovitz, Rony | Mr. Rony A. Abovitz, Senior Vice President and Chief Technology Officer of MAKO Surgical Corp., has been with the Company since its inception in November 2004. Mr. Abovitz was a co-founder of Z-KAT, Inc., and from 1997 to November 2004, he held various executive positions, including Chief Executive Officer and Chief Technology Officer. From 1994 to 1996, Mr. Abovitz worked as a research and development engineer for Lima Orthopedics, Inc. developing orthopedic implants. Mr. Abovitz holds a B.S. in mechanical engineering and an M.S. in biomedical engineering from the University of Miami. |
| Frank, Menashe | Mr. Menashe R. Frank, Senior Vice President, General Counsel and Secretary of MAKO Surgical Corp., has been with the Company since its inception in November 2004. From July 2004 to November 2004, Mr. Frank was a legal consultant to Z-KAT, Inc. Mr. Frank was a corporate associate at the law firm of Hogan & Hartson LLP from 2001 to June 2004, and the law firm of Baker & McKenzie from 2000 to 2001. From 1998 to 2000, Mr. Frank served as Chief Legal Officer for Enticent.com, Inc., a marketing technology enterprise. He was also an associate in the business finance and restructuring department of the law firm of Weil, Gotshal & Manges LLP from 1996 to 1998. Mr. Frank holds a B.A. in political science from American University and a J.D. from the University of Miami School of Law. |
| Nunes, Steven | Mr. Steven J. Nunes, Senior Vice President of Sales and Marketing of MAKO Surgical Corp., has been with the Company since May 2006. From September 2002 to May 2006, Mr. Nunes served as Director of Commercialization for GE Healthcare, a unit of General Electric Company, a diversified technology, media, and financial services company. From 1996 to April 2002, Mr. Nunes held various positions, including Vice President of Sales and Marketing, at Visualization Technology, Inc., a medical device company for image-guided surgery, which was later acquired by GE Healthcare. In 1990, Mr. Nunes established SJN Medical Inc., an independent distributor of surgical endoscopy products, and served as its President until the company was acquired in 1996. Mr. Nunes holds a B.A. in broadcast journalism from the University of Massachusetts-Amherst. |
| Delevic, Ivan | Mr. Ivan Delevic, Senior Vice President of Strategic Marketing and Business Development of MAKO Surgical Corp., joined the company in April 2009. Beginning in 2007 through April 2009, Mr. Delevic was a business development consultant to medical device companies through ATID Group Inc. and IDAT LLC, companies he founded in 2007. From 1996 to 2007, Mr. Delevic held various positions with General Electric’s healthcare division, both domestically and internationally, including as General Manager for Molecular Imaging EMEA, Global Marketing and Sales Manager for Surgical Navigation, Business Development Manager with GE Healthcare’s Global Business Development, Six Sigma Leader & Black Belt for Global Functional Imaging, and Sales Manager for Southeastern Europe. From 1992 to 1996, Mr. Delevic worked for Johnson & Johnson, Inc. as a Business Manager in Budapest, Hungary. Mr. Delevic holds a M.B.A. from the Technical University of Budapest through a joint program with Herriot-Watt University and a M.S. in Electrical Engineering from the Technical University of Budapest. |
| Moffat, Duncan | Mr. Duncan H. Moffat, Senior Vice President of Operations of MAKO Surgical Corp., has been with the Company since April 2008. From 2001 to 2008, Mr. Moffat served as Vice President of Operations for the nuclear medicine business of Philips Medical Systems, a worldwide manufacturer of medical imaging equipment. From 1998 to 2001, Mr. Moffat served as Vice President of Operations for Lumisys, a start-up company providing digital x-ray products that was sold to Eastman Kodak in 2001. Beginning in 1982, Mr. Moffat held various positions with the Lucas companies, first with two Lucas affiliates in England, followed by a position as project manager with Lucas Control Systems Products, Hampton, Virginia, and then by a position as Director of Operations with Lucas Deeco Systems, Hayward, California, from 1995 to 1998. Mr. Moffat holds a Bachelor of Science in Electrical and Electronic Engineering, Strathclyde University, Glasgow, Scotland. |
| Federico, Charles | Mr. Charles W. Federico, Lead Director, has served as one of the Directors of MAKO Surgical Corp. since June 2007. From 2001 to April 2006, Mr. Federico served as President and Chief Executive Officer of Orthofix International N.V., a global diversified medical device company, and, from 1996 to 2001, President of Orthofix Inc. From 1985 to 1996, Mr. Federico was President of Smith & Nephew Endoscopy (formerly Dyonics, Inc.). From 1981 to 1985, Mr. Federico served as Vice President of Dyonics. Previously, he held management and marketing positions with General Foods Corporation, Puritan Bennett Corporation and LSE Corporation. Mr. Federico is a Trustee of the Orthopedic Research and Education Foundation and a director of Orthofix International N.V., SRI/Surgical Express, Inc., BioMimetic Therapeutics, Inc., Power Medical Innovations, and Alveolus, Inc. Mr. Federico holds a B.S. in marketing from Fordham University. |
| Blumenfeld, S. Morry | Dr. S. Morry Blumenfeld, Ph.D. has served as one of the Directors of MAKO Surgical Corp. since July 2005. In 2003, Dr. Blumenfeld founded Meditech Advisors LLC and Meditech Advisors Management LLC, a member of Ziegler MediTech Partners, LLC, the sole general partner of Ziegler Meditech Equity Partners, LP, a private equity fund specializing in investments in healthcare and medical device companies. In April 2002, Dr. Blumenfeld retired as Managing Director of GE Medical Systems in Israel after more than 34 years with the company, where he helped initiate both GE’s CT and MR business lines. Currently, he serves on the board of directors of a number of medical device and technology companies, including Oridion Systems Ltd. and several private companies. Dr. Blumenfeld holds a B.A.Sc in engineering physics and a Ph.D. in molecular physics from the University of Toronto. |
| Chao, Marcelo | Mr. Marcelo G. Chao has served as one of the Directors of MAKO Surgical Corp. since February 2007. He is a Managing Director at The Exxel Group, an affiliate of MK Investment Company, which he joined in March 2000. From 1995 to 2000, Mr. Chao was a Partner at Hermes Management Consulting. From 1992 to 1995, Mr. Chao was Vice President of Citibank in Buenos Aires, Argentina, and from 1991 to 1992 he worked for McKinsey & Company. Currently, Mr. Chao serves on the board of directors of several Exxel Group portfolio companies. Between November 2002 and December 2006, Mr. Chao also served on the Latin American and Caribbean board of MasterCard International. Mr. Chao holds a B.S. in business administration from Universidad Católica Argentina and is a Certified Public Accountant. |
| Dewey, Christopher | Mr. Christopher C. Dewey has served as one of the Directors of MAKO Surgical Corp. since its inception in November 2004. Since January 2007, Mr. Dewey has served as Vice Chairman of the board of directors of National Holdings Corporation, a financial services organization operating through its subsidiary, National Securities. From December 2006 to December 2008, Mr. Dewey served as acting Chief Executive Officer and director of Z-KAT, Inc. Mr. Dewey has over 25 years of experience in finance, most recently as Executive Vice President of Jefferies & Company, Inc., the principal operating subsidiary of Jeffries Group, Inc., a securities and investment banking firm, from 1994 to December 2006. Mr. Dewey co-founded several companies, including Robotic Ventures LLC, Bonds Direct Securities LLC and Cannon Group Inc., a motion picture company that went public in 1972. Mr. Dewey holds an M.B.A. from The Wharton School of the University of Pennsylvania. |
| Moll, Frederic | Dr. Frederic H. Moll, M.D. has served as one of the Directors of MAKO Surgical Corp. since August 2007. In September 2002, Dr. Moll co-founded Hansen Medical, Inc., a medical robotics company, and serves as its Chief Executive Officer and is a member of its board of directors. In November 1995, Dr. Moll co-founded Intuitive Surgical, Inc., a medical device company, and served as its first Chief Executive Officer and later, its Vice President and Medical Director until September 2003. In 1989, Dr. Moll co-founded Origin Medsystems, Inc., a medical device company, which later became an operating company within Guidant Corporation, a medical device company, following its acquisition by Eli Lilly in 1992. Dr. Moll served as Medical Director of Guidant’s surgical device division until November 1995. Dr. Moll holds a B.A. from the University of California, Berkeley, an M.S. from Stanford University and an M.D. from the University of Washington School of Medicine. |
| Pruitt, William | Mr. William D. Pruitt has served as one of the Directors of MAKO Surgical Corp. since June 2008. Mr. Pruitt is president of Pruitt Enterprises, LP. Mr. Pruitt has been a board member of The PBSJ Corporation, an international professional services firm, since July 2005 and has been the chairman of the PBSJ audit committee since 2003. Mr. Pruitt served as chairman of the audit committee of KOS Pharmaceuticals, Inc., a fully integrated specialty pharmaceutical company, until its sale in 2006. He was also chairman of the audit committee for Adjoined Consulting, Inc., a full-service management consulting firm, until it was merged into Kanbay International, a global consulting firm, in February 2006. From 2002 to 2004, Mr. Pruitt provided market consultancy services to Ernst & Young LLP, the Company's independent registered public accounting firm. From 1980 to 1999, Mr. Pruitt served as the managing partner for the Florida, Caribbean and Venezuela operations of the independent auditing firm of Arthur Andersen LLP. Mr. Pruitt holds a Bachelor of Business Administration from the University of Miami and is a Certified Public Accountant (inactive). |
| Savarese, John | Dr. John J. Savarese, M.D. has served as one of the Directors of MAKO Surgical Corp. since October 2008. Since June 2003, Dr. Savarese has been a Managing Director at Montreux Equity Partners, a life sciences investment firm. Prior to joining Montreux Equity Partners, Dr. Savarese served as Director of Business Development and Marketing at NeurogesX and worked in the Life Sciences Investment Banking division of Credit Suisse First Boston. Currently, Dr. Savarese serves on the board of directors of several medical device and pharmaceutical companies. Dr. Savarese’s clinical experience in Orthopedic and General Surgery was gained at the Cornell Medical College/Hospital for Special Surgery. Dr. Savarese holds an M.B.A from Stanford University and an M.D. from Duke University Medical School. |
| Freund, John | Dr. John G. Freund, M.D. has served as one of the Directors of MAKO Surgical Corp. since October 2008. Since 1997, Dr. Freund has been a Managing Director of Skyline Ventures, a venture capital firm. From September 1995 to September 1997, Dr. Freund was a Managing Director in the private equity group at Chancellor Capital Management, an investment firm. In 1995, Dr. Freund co-founded Intuitive Surgical, Inc., a medical device company, and served on Intuitive’s board of directors until March 2000. From June 1988 to December 1994, Dr. Freund held various positions at Acuson Corporation, a medical device company, including Executive Vice President. From 1982 to 1988, Dr. Freund was at Morgan Stanley & Co., Inc., an investment banking firm, where he was the co-founder of the Healthcare Group in the Corporate Finance Department and later was the original healthcare partner at Morgan Stanley Venture Partners, a venture capital management firm affiliated with Morgan Stanley. Dr. Freund also serves on the board of directors of Hansen Medical, Inc., XenoPort Inc., MAP Pharmaceuticals, Inc., the New Economy Fund, and the SmallCap World Fund, as well as a number of private companies. Dr. Freund received an M.D. from Harvard Medical School in 1980 and an M.B.A. from Harvard Business School in 1982, where he was a Baker Scholar. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
| Ferre, Maurice | 1,642,970 |
| LaPorte, Fritz | 402,317 |
| Abovitz, Rony | 463,250 |
| Frank, Menashe | 399,046 |
| Nunes, Steven | 239,091 |
| Delevic, Ivan | -- |
| Moffat, Duncan | 431,709 |
| Federico, Charles | -- |
| Blumenfeld, S. Morry | -- |
| Chao, Marcelo | -- |
| Dewey, Christopher | -- |
| Moll, Frederic | -- |
| Pruitt, William | -- |
| Savarese, John | -- |
| Freund, John | -- |
As Of 30 Dec 2008
Options Compensation
| Name | Options | Value |
|---|---|---|
| Ferre, Maurice | 206,672 | 90,763 |
| LaPorte, Fritz | 0 | 0 |
| Abovitz, Rony | 20,000 | 149,133 |
| Frank, Menashe | 0 | 0 |
| Nunes, Steven | 0 | 0 |
| Delevic, Ivan | 0 | 0 |
| Moffat, Duncan | 0 | 0 |
| Federico, Charles | 0 | 0 |
| Blumenfeld, S. Morry | 0 | 0 |
| Chao, Marcelo | 0 | 0 |
| Dewey, Christopher | 0 | 0 |
| Moll, Frederic | 0 | 0 |
| Pruitt, William | 0 | 0 |
| Savarese, John | 0 | 0 |
| Freund, John | 0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
| FERRE MAURICE R | 10,000 | $12.54 |
| FERRE MAURICE R | 2,075 | $11.50 |
| FERRE MAURICE R | 6,300 | $11.56 |
| FERRE MAURICE R | 1,625 | $11.50 |
| ABOVITZ RONY A | 4,234 | $1.27 |
| ABOVITZ RONY A | 4,234 | $11.39 |
| MOLL FREDERIC H | 10,000 | $8.58 |
| DEWEY CHRISTOPHER C | 8,596 | $9.20 |
| FERRE MAURICE R | 5,639 | $9.00 |
| ABOVITZ RONY A | 2,000 | $8.80 |
| ABOVITZ RONY A | 2,000 | $0.67 |
| ABOVITZ RONY A | 5,000 | $0.67 |
| FERRE MAURICE R | 10,195 | $8.95 |
| BLUMENFELD S MORRY | 67,236 | $0.00 |
| ABOVITZ RONY A | 5,000 | $8.93 |
| MOLL FREDERIC H | 20,000 | $9.01 |
| FERRE MAURICE R | 5,000 | $9.23 |
| FERRE MAURICE R | 5,000 | $8.47 |
| SAVARESE JOHN | 632,000 | $7.25 |
| SKYLINE VENTURE PARTNERS V L P | 758,000 | $7.25 |
| FERRE MAURICE R | 40,211 | $8.70 |
| FERRE MAURICE R | 100,000 | $0.00 |
| ABOVITZ RONY A | 1,745 | $0.67 |
| ABOVITZ RONY A | 1,745 | $7.65 |
| ABOVITZ RONY A | 2,355 | $7.55 |





